Mo X D, Huang X J
Peking University People's Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
Zhonghua Xue Ye Xue Za Zhi. 2024 Jul 14;45(7):625-628. doi: 10.3760/cma.j.cn121090-20240215-00061.
The lack of donors is the biggest obstacle to the widespread use of hematopoietic stem cell transplantation. The establishment and improvement of new transplantation schemes have made haploid hematopoietic stem cell transplantation a clinical routine, benefiting a large number of patients with hematological diseases. Haploid donors have become the most important source of donors for allogeneic hematopoietic stem cell transplantation in China. This article focuses on the current situation and future development trends of haploid hematopoietic stem cell transplantation in China, in order to increase the understanding of clinical doctors on haploid hematopoietic stem cell transplantation.
供体短缺是造血干细胞移植广泛应用的最大障碍。新移植方案的建立和完善使单倍体造血干细胞移植成为临床常规操作，造福了大量血液病患者。单倍体供体已成为我国异基因造血干细胞移植最重要的供体来源。本文重点介绍我国单倍体造血干细胞移植的现状及未来发展趋势，以提高临床医生对单倍体造血干细胞移植的认识。
